ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 111702 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 111702; 2) Community: the network communities that were significantly associated with the response to NSC 111702; 3) Molecule: the relationships between components within communities and NSC 111702; 4) MDR: the compounds that were significantly associated with the NSC 111702.

NSC Compound Enrichment Correlation
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.00714731931708452 0.20687357
NSC 251668 OVATIFOLIN ACETATE 0.00714731931708452 0.42505976
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.00714731931708452 -0.28763704
NSC 636859 Cuspidatin C 0.00714731931708452 0.35464739
NSC 698148 Null 0.00714731931708452 0.40774585
NSC 174121 Methotrexate Derivative 0.00744479268267744 0.32966613
NSC 631197 9-N-(N'-chloroethyl-N'-ethyl-1,4-diamino-butyl)2-methoxy acridine dihydrochloride 0.00744479268267744 0.43062429
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.00744479268267744 0.25166127
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.00744479268267744 0.39679941
NSC 740252 Null 0.00744479268267744 0.4423168
Total:65  Current:11    [First] [Prev] [Next] [Last]